Many patients stay on treatment for several months to a year
Our physician-guided GLP-1 program delivers clinically proven results with the ongoing support to sustain them long term
The effect of GLP-1 receptor agonists on cardiac remodeling in heart failure patients with preserved and reduced ejection fraction: a systematic review and meta-analysis
Stopping SGLT-2 inhibitors during intercurrent illness mitigates the risk of DKA
Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, et al
At BioPrime Medical, we offer BPC-157 peptide therapy, a cutting-edge treatment designed to promote healing, reduce inflammation, and enhance overall health